Outcomes associated with allogeneic hematopoietic stem cell transplantation for relapsed and refractory Hodgkin lymphoma in the era of novel agents
Sign Up to like & getrecommendations! Published in 2023 at "Cancer Medicine"
DOI: 10.1002/cam4.5631
Abstract: Relapsed or refractory Hodgkin lymphoma (R/R HL) is a challenging disease with limited treatment options beyond brentuximab vedotin and checkpoint inhibitors. Herein we present the time‐trend analysis of R/R HL patients who received allogeneic hematopoietic… read more here.
Keywords: hodgkin lymphoma; allogeneic hematopoietic; refractory hodgkin; relapsed refractory ... See more keywords
Nivolumab for relapsed or refractory Hodgkin lymphoma: Experience in Turkey
Sign Up to like & getrecommendations! Published in 2017 at "Hematological Oncology"
DOI: 10.1002/hon.2439_63
Abstract: secondary endpoints. Patients and Methods: Between 8/2011 and 2/2017, 102 pts that received BV were reported. Median age was 32 (range, 16‐73), 56 (55%) were primary refractory. Sixty‐six (65%) received BV after ASCT failure, and… read more here.
Keywords: relapsed refractory; hodgkin lymphoma; refractory hodgkin; pts received ... See more keywords
Gemcitabine, vinorelbine and dexamethasone: A safe and effective regimen for treatment of relapsed/refractory hodgkin's lymphoma.
Sign Up to like & getrecommendations! Published in 2019 at "Leukemia research"
DOI: 10.1016/j.leukres.2019.106188
Abstract: BACKGROUND Salvage regimens in relapsed/refractory Hodgkin's lymphoma (HL) differ in their efficacy and toxicity profiles. Gemcitabine (G), vinorelbine (V) and liposomal doxorubicin (GVDoxil) is one regimen with high response rates but has high toxicity and… read more here.
Keywords: relapsed refractory; hodgkin lymphoma; refractory hodgkin; gvdex ... See more keywords
Outcome of a patient with refractory Hodgkin lymphoma on pembrolizumab, infected with SARS‐CoV‐2
Sign Up to like & getrecommendations! Published in 2020 at "British Journal of Haematology"
DOI: 10.1111/bjh.16798
Abstract: A 22-year-old female presented the Emergency Department on the 14th March 2020 with a 3 day history of cough, pyrexia, sore throat, chills and rigors. Dyspnoea, myalgia, anosmia did not feature at presentation. The patient… read more here.
Keywords: patient refractory; lymphoma; hodgkin lymphoma; outcome patient ... See more keywords
Brentuximab Vedotin Following Autologous Transplantation in Pediatric Patients with Relapsed/Refractory Hodgkin Lymphoma.
Sign Up to like & getrecommendations! Published in 2023 at "Blood advances"
DOI: 10.1182/bloodadvances.2022009323
Abstract: Outcomes for children and adolescents with relapsed and refractory Hodgkin lymphoma (HL) are poor, with approximately 50% of patients experiencing a subsequent relapse. The anti-CD30 antibody-drug conjugate brentuximab vedotin improved progression-free survival (PFS) when used… read more here.
Keywords: refractory hodgkin; relapsed refractory; brentuximab vedotin; hodgkin lymphoma ... See more keywords
Gemcitabine, dexamethasone, and cisplatin (GDP) as an effective therapy as salvage and mobilization regimen in patients with relapsed or refractory Hodgkin lymphoma.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.15_suppl.e19517
Abstract: e19517Background: The best combination chemotherapy as a salvage and mobilization regimen in patients with relapsed or refractory Hodgkin lymphoma ( HL) remains unknown. We retrospectively analysed... read more here.
Keywords: relapsed refractory; refractory hodgkin; mobilization regimen; salvage mobilization ... See more keywords
Insights into uveitis from Brentuximab vedotin in refractory Hodgkin’s lymphoma: a case report and brief review
Sign Up to like & getrecommendations! Published in 2024 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2024.1419145
Abstract: This case report describes a 16-year-old patient with refractory Hodgkin’s lymphoma who developed bilateral anterior and intermediate uveitis as an adverse reaction to Brentuximab vedotin (BV). This is a rare case of an ocular adverse… read more here.
Keywords: refractory hodgkin; case report; case; brentuximab vedotin ... See more keywords